Navigation Links
Low-dose Growth Hormone (GH) with diet and exercise may help weight loss

Growth Hormone (GH) replacement therapy dosed to normalize IGF-I levels may be an effective adjunct to lifestyle modification in a "clinically necessary" weight loss program for obese adults.
The goal of all weight loss programs is to lose body fat but retain lean body mass such as muscle,but what happens is that when people go on a diet, after a while, they stop losing weight. Low levels of GH, known to occur with obesity, may be to blame.// When GH is low, the body tends to accumulate body fat and lose muscle, and energy levels are low.

Past studies of GH replacement in obesity have involved extremely high doses of GH, which were found to have side effects. Researchers tested the effects of adding a low-dose of GH to lifestyle modification in the treatment of obese patients.The dose of GH was calculated to replace the normal amount the body would make if the patients were not obese. Researchers randomized 59 obese subjects 20 to 45 years of age, to exercise, a calorie-restricted diet, and either human GH or placebo administered by nightly injections for six months. Thirty-nine completed the protocol.

After 6 months, subjects in the GH arm had lost about 5 pounds and the shed pounds did not return during the 3-month GH-free follow-up period. Importantly,the weight loss was entirely made up of body fat, largely in the abdominal area. The patients did not lose any muscle mass. Weight loss in the control arm was not significant. Changes in body fat in the GH arm correlated with normalization of IGF-I levels.

GH-treated subjects also exhibited a 19% increase in HDL cholesterol, which may have a long-term benefit in protecting these people from heart disease. GH therapy did not alter LDL, VLDL, triglycerides, glucose, insulin, insulin sensitivity, resting energy expenditure or blood pressure. GH therapy was well tolerated with only one subject discontinuing due to edema.

The reason for loss of weight has not been kn
'"/>




Page: 1 2

Related medicine news :

1. Low-dose Aspirin Benefits Both Sexes
2. Low-dose Aspirin Beats High-dose After Cardiac Surgery
3. Low-dose Omega-3 Linked to Lower Blood Pressure
4. Clinical Trials for a Low-dose Steroid Therapy for Bone Marrow Cancer Prove Positive
5. Anti-Cancer Drug Restores Normal Cell Growth
6. Human Growth Hormone Found To be Dangerous For Human Use
7. Stem Cells Found To Offer Promise For Hair Growth
8. Fish Found To Improve Fetal Growth
9. Growth Patterns In Childhood Could Predict Breast Cancer Later In Life
10. Stopping The Growth Of Viruses
11. Stopping The Growth Of Viruses

Post Your Comments:
(Date:11/25/2009)...nn.,Nov.25/PRNewswire-USNewswire/--Whenmostpeopleh...practorcanalsogivepatientsthehelptheyneed.TMJstand...w(mandible)contacts/connectswithyourskull(temporal...Jdysfunctionarepainwithchewing,clickingorpoppingof...nctionincluding:headaches,fatigue,sleepdisturbance...
(Date:11/25/2009)...Nov.25/PRNewswire/-SentinelleMedicalInc.,aleadingm...nsoftwarelaunchesasuiteofnewleadingedgeclinicalapp...ormatthisyear,sRadiologicalSocietyofNorthAmerica(R...5800,HallA).Theapplicationsleveragetheuniquehighqu...agingcoilsandsupportmultipleimagingmodalitiesformu...
(Date:11/25/2009)...ISCO,Nov.25/PRNewswire/--TheBayAreaAirQualityManag...pare the Air Alert forThursday,November...anyothersolidfuel,bothindoorsandoutdoors. ,, "C...ytomorrow,"saidJackBroadbent,executiveofficerofthe...hehealthoftheirneighborsandfellowcommunitymemberst...
(Date:11/25/2009)... discovery that grew out of a collaboration betwee...offer hope to the nearly 10 million Americans who ...lso known as hardening of the arteries, peripheral... problem in which narrowed arteries reduce blood f...d flag for vascular disease, heart attack and stro...
(Date:11/25/2009)... Evaluation and treatment clinics to resu...stock (Vocus) November 25, 2009 -- Centegra Health... and H1N1 vaccine shots at four Centegra Primary C...nt of vaccine has arrived. The clinics are at CPC ...nry and will be open as follows: ,   F...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4
...TIN, Texas, May 22 Whole Foods Market,(Nasdaq: W...ds supermarket,announced today it has launched "De...s America, whether it be at backyard barbecues, fa...kes to win,Weber(R) Grills and a VIP concert trip ...
...MADISON - In our brains, where millions of signals...a relay race, all the critical baton passes take p...ell endings have to be just the right size for mes...ties, and other neurological disorders. , In a f...
...puter-based test delivery provides greater conveni... certification, WASHINGTON, May 22 The Pharmacy ...day that over 300,000 pharmacy,technicians have of...ion or transfer process since the program,s incept...
...line in function needs to be addressed more aggres...ealthDay News) -- Children with sickle cell diseas... as they age, compared with other children of the ...n obstructive or asthma-like pattern. , "The rest...
...CHICAGO (May 22, 2008) - As people begin to realiz...life, many are turning to alternative methods to p...y economically feasible to wear while waiting for ... issue of General Dentistry, the Academy of Genera...
...TA MONICA, Calif., May 22 The California,Senate r... firm that was,forced to change its name after pri...w., The bill, SB 1096 (Calderon), which was grant...medical information --,including a patient,s illne...
Other Medicine News:Health News:Whole Foods Market's(R) 'Destination Summer' Celebrates a Journey of American Flavors; Kicks Off With Sweepstakes & Free Shopper Grilling Guide 2Health News:Whole Foods Market's(R) 'Destination Summer' Celebrates a Journey of American Flavors; Kicks Off With Sweepstakes & Free Shopper Grilling Guide 3Health News:Whole Foods Market's(R) 'Destination Summer' Celebrates a Journey of American Flavors; Kicks Off With Sweepstakes & Free Shopper Grilling Guide 4Health News:At the synapse: Gene may shed light on neurological disorders 2Health News:At the synapse: Gene may shed light on neurological disorders 3Health News:Pharmacy Technician Certification Board (PTCB) Announces Milestone: 300,000 Certified Pharmacy Technicians (CPhT) 2Health News:Pharmacy Technician Certification Board (PTCB) Announces Milestone: 300,000 Certified Pharmacy Technicians (CPhT) 3Health News:Lung Trouble Associated With Sickle Cell in Kids 2Health News:Temporary dentures improve patients' smiles and overall health 2Health News:Sponsor of Drug Bill Rejected by CA Senate Today Changed Its Name After Privacy Violations 2Health News:Sponsor of Drug Bill Rejected by CA Senate Today Changed Its Name After Privacy Violations 3
(Date:11/25/2009)...AccordingtoMillenniumResearchGroup(MRG),theglobala...early$3billionUSmarketfortraumafixationdeviceswill...etherecenteconomicslowdown.MRG,s USMarketsforTraum...highlydynamicoverthenextfiveyears,withcompetitorsi...dsegmentsofthetraumafixationmarket,fuelingmarketgr...
(Date:11/25/2009)...linker.comannouncesthatanewmarketresearchreportisa...ery-USMarketTrends&Analysis http://www.report...Market-Trends--Analysis.html ,, TheUSintranasa...euticapplicationsfromthedeliveryofconventionalloca...cdrugs.Thefutureofthetechnologyhingesontotheeffect...
(Date:11/24/2009)...a/--ChindexInternational,Inc.,("Chindex")(Nasdaq: ...n,healthcareproductsandservicesinthePeople,sRepubl...he21stAnnualPiperJaffray,"Unplugged"HealthCareConf...eHotel. , Managementiscurrentlyscheduledtopre...e-on-onemeetingsthroughouttheday.Awebcast,ofthepre...
Breaking Medicine Technology:US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5Chindex International to Present at Piper Jaffray Health Care Conference 2EF Johnson Technologies Inc Highlights New Products at APCO 2009 54570 1EF Johnson Technologies Inc Highlights New Products at APCO 2009 54570 2EF Johnson Technologies Inc Highlights New Products at APCO 2009 54570 3Statewide program to improve emergency care for children 54567 1Statewide program to improve emergency care for children 54567 2Scientists take early steps toward mapping epigenetic variability 9583 1Scientists take early steps toward mapping epigenetic variability 9583 2
...udy to Show That Extended,Thromboprophylaxis Reduc... Statistically Significant 44% , PARIS, July 8, 20...ed today the results of the EXCLAIM (EXtended CLin...study, which showed,the benefit of extended prophy... mobility by demonstrating the superiority of 5 we...
...Inc. (NASDAQ:INSM), a ,biopharmaceutical company f...r the treatment of metabolic diseases with unmet,...nt at this,week,s C.E. Unterberg, Towbin (CEUT) Em... City. , The conference, to be held at the Mand...om Tuesday, July 10th through Thursday,July 12th....
Other Medicine Technology:New Study Shows That Extending Prophylaxis With Clexane / Lovenox,(enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10,Days for Reducing the Risk of Venous Thromboembolism (VTE) in,Acutely ill Medical Patients With Reduced Mobility 2New Study Shows That Extending Prophylaxis With Clexane / Lovenox,(enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10,Days for Reducing the Risk of Venous Thromboembolism (VTE) in,Acutely ill Medical Patients With Reduced Mobility 3New Study Shows That Extending Prophylaxis With Clexane / Lovenox,(enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10,Days for Reducing the Risk of Venous Thromboembolism (VTE) in,Acutely ill Medical Patients With Reduced Mobility 4New Study Shows That Extending Prophylaxis With Clexane / Lovenox,(enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10,Days for Reducing the Risk of Venous Thromboembolism (VTE) in,Acutely ill Medical Patients With Reduced Mobility 5New Study Shows That Extending Prophylaxis With Clexane / Lovenox,(enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10,Days for Reducing the Risk of Venous Thromboembolism (VTE) in,Acutely ill Medical Patients With Reduced Mobility 6Insmed Inc. to Present at C.E. Unterberg, Towbin Growth Conference 2
P-1069-A-SS
P-1068-A-SS
P-1066-SS
..., solid cast aluminum frame, armrest, footrest, an...tion full range articulating headrest, securely lo...red cushions with anti-viral upholstery, self-lubr...colors. Optional features: foot pedal control, sin...
Medicine Products: